http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Magnetic Actuator for a Capsule Endoscope Navigation System
Atsushi Chiba,Masahiko Sendoh,Kazushi Ishiyama,Ken Ichi Arai,Hironao Kawano,Akio Uchiyama,Hironobu Takizawa 한국자기학회 2007 Journal of Magnetics Vol.12 No.2
The authors propose a magnetic actuator for use as a navigation system for capsule endoscopes. The actuator is composed of a capsule dummy, a permanent magnet inside the capsule, and an external spiral structure. The device rotates and propels wirelessly when exposed to an external rotational magnetic field. In this study we measured the effect of the spiral shape on the velocity and thrust force properties. According to our experimental results, the actuator obtained a maximum velocity and thrust force when the spiral angle was set at 45 degrees, the number of spirals was set at 4, and the spiral-height was set at 1-㎜f. We also conducted a motion test in the large intestine of a pig placed on a 30 degrees slope. The actuator passed through a 700 ㎜ length of the intestine in about 300 s. The device also managed to travel up and down the 30 degrees slope with no difficulty whatsoever. Our results demonstrate the great potential of this actuator for use as a navigation system for capsule endoscopes.
Bispectral index-guided propofol sedation during endoscopic ultrasonography
Ayana Okamoto,Ken Kamata,Takeshi Miyata,Tomoe Yoshikawa,Rei Ishikawa,Tomohiro Yamazaki,Atsushi Nakai,Shunsuke Omoto,Kosuke Minaga,Kentaro Yamao,Mamoru Takenaka,Yasutaka Chiba,Toshiharu Sakurai,Naoshi 대한소화기내시경학회 2022 Clinical Endoscopy Vol.55 No.4
Background/Aims: Bispectral index (BIS) monitors process and display electroencephalographic data are used to assess the depth ofanesthesia. This study retrospectively evaluated the usefulness of BIS monitoring during endoscopic ultrasonography (EUS). Methods: This study included 725 consecutive patients who underwent EUS under sedation with propofol. BIS monitoring was usedin 364 patients and was not used in 361. The following parameters were evaluated: (1) median dose of propofol; (2) respiratory and circulatorydepression; (3) occurrence of body movements; (4) awakening score >8 at the time; and (5) awakening score 2 hours afterleaving the endoscopy room. Results: The BIS group received a significantly lower median dose of propofol than the non-BIS group (159.2 mg vs. 167.5 mg;p=0.015) in all age groups. For patients aged ≥75 years, the reduction in heart rate was significantly lower in the BIS group than in thenon-BIS group (1.2% vs. 9.1%; p=0.023). Moreover, the occurrence of body movements was markedly lower in the BIS group than inthe non-BIS group (8.5% vs. 39.4%; p<0.001). Conclusions: During EUS examination, BIS monitoring is useful for maintaining a constant depth of anesthesia, especially in patients75 years of age or older.
Hiroyuki Kaji,Akira Togayachi,Makoto Ochou,Maki Sogabe,Takashi Okura,Hirofumi Nozaki,Takashi Angata,Yasunori Chiba,Hidenori Ozaki,Atsushi Kuno,Yasuhito Tanaka,Yuzuru Ikehara,Masashi Mizokami,Hisashi N 한국당과학회 2012 한국당과학회 학술대회 Vol.2012 No.1
We present here a high-throughput strategy to discover serological biomarkers for early-detection of hepatocellular carcinoma (HCC). Our strategy is also applicable to assess the progressed liver fibrosis that is associated with virus hepatitis. The glycan structure on glycoproteins derived from cancerous cells is known to be different from that derived from normal cells, specifically, the increased aberrant glycosylation appears in patient serum with virus hepatitis along with either or both the initiation and progression. Based on the above perceptions, in order to identify glycoproteins carrying aberrant glycosylation in serum of liver disease patients, we analyzed lectin-captured glycopeptides by the IGOT method. Many glycoproteins carrying altered glycans were successfully identified. The increased amount of these glycoproteins was clinically relevant to the progression of the liver diseases. We are now selecting appropriate molecules depending on the feasibility to detect an abnormality in the liver, such as the occurrence of liver cell neoplasm.